{"name":"ayesha tariq","slug":"ayesha-tariq","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"intravenous levetireacetam","genericName":"intravenous levetireacetam","slug":"intravenous-levetireacetam","indication":"Adjunctive therapy for partial-onset seizures","status":"marketed"}]}],"pipeline":[{"name":"intravenous levetireacetam","genericName":"intravenous levetireacetam","slug":"intravenous-levetireacetam","phase":"marketed","mechanism":"Levetiracetam reduces neuronal excitability and seizure activity through binding to synaptic vesicle protein SV2A, modulating neurotransmitter release.","indications":["Adjunctive therapy for partial-onset seizures","Adjunctive therapy for myoclonic seizures in patients with juvenile myoclonic epilepsy","Adjunctive therapy for primary generalized tonic-clonic seizures"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxQMTk2SE9NV0oxN05TeXo2YVBHb21oSi1OcWZzX0gzRHp0U2JnVmhKLXFveDdVRjhGVFdveG1fWGZoa3lXVFJMdGp4TXZRRnJRa2JhQ0VxVHdKSXVGTHlWd3NTVUMxdVk3aXdpV2VSMGFZMnk5SW1MY3gwQmc5S3YzRElUbGY0Y2ZNZENWMFVZdS0takxURUVYRG1kMTNPLUdKVkZMRHhlQ3VJYm9PR2hyTGx4QWo1Tm1H?oc=5","date":"2024-09-23","type":"pipeline","source":"National Institute on Drug Abuse (NIDA) (.gov)","summary":"Virginia Commonwealth University Welcomes 2024-2025 Hubert H. Humphrey Fellows - National Institute on Drug Abuse (NIDA) (.gov)","headline":"Virginia Commonwealth University Welcomes 2024-2025 Hubert H. Humphrey Fellows - National Institute on Drug Abuse (NIDA)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOQnFab3FfbTlTWkFsck1pdUFxdGxDcV9IanFQV0ZHMUptazc2NXhkQUczdUltNE94WVo3MlZXbVhhUUhuWTJwQWRxZ3RrR1RXQ1BlY3I2dzMtd0hjMlkzM3A0akJuTTBhNWw3M1E4WEVlUXRGZlhYVXZJemw1aTIyTEsyUjJwSkZRUENiN0VVdWpQbEJuTFAwRk01WDI?oc=5","date":"2024-06-24","type":"pipeline","source":"| Associated Press Of Pakistan","summary":"KU awards 125 MPhil, 52 PhD, other degrees in various disciplines - | Associated Press Of Pakistan","headline":"KU awards 125 MPhil, 52 PhD, other degrees in various disciplines - | Associated Press Of Pakistan","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}